Hope in Cancer Therapy. Reinhard Probst
two blood transfusions, with an increased bilirubin level that could no longer be treated with conventional medicine and with a tumor marker that had increased sevenfold, the patient left the hospital in a wheelchair after four weeks, weakened and traumatized by her experiences and the words of the doctors.
With the help of Dr. Probst, she was able to find peace and rest for the first time since the diagnosis, although the advanced metastasis demanded much from her body. Dr. Probst always met our relatives on an equal footing. He was open, honest and always supportive. He gave us the recipes we needed to treat her at home. Since we took a very unconventional route, we were in the care, medication and with complications on our own with all the implications of that.
Palliative service provides support only when you are no longer being treated. One of the patient's relatives is a nurse and provided her with daily medical care; otherwise it would not have been possible to follow this humane path of treatment.
Dr. Probst answered our critical questions very patiently, regularly monitored the course of his treatment using a weekly tumor marker and blood count, and repeatedly made corrections to optimize the therapy for the patient. In his empathic manner, he was pleased with our good results and regretted the complications caused by the advanced disease.
Twice a week we went to his practice, where he treated the patient with insulin-potentiation chemotherapy, curcumin, high doses of vitamin C and local hyperthermia. When after the first treatment the tumor markers had decreased by 80%, the impossible had happened according to orthodox medicine. After that, however, the marker value rose again and again. The cells seemed to have become resistant. Dr. Probst changed the composition of the insulin-potentiation therapy. In addition, he gave us a prescription for D,L-methadone for pain relief and because of the apparent resistance. We had now heard about it from acquaintances and absolutely wanted to try it out. He supported us in that.
After one day of taking methadone, the patient was like a different person - without pain, awake and with a clear mind and an appetite. From then on she wanted and was able to eat three small meals a day in addition to artificial nutrition. The effect was exactly as we had read it in various publications about D,L-methadone. The yellow of the bilirubin in her eyes and skin gradually disappeared. We were allowed to experience this change with our own eyes. We continued to follow Dr Probst's instructions, discontinuing other painkillers and increasing the dose of methadone daily.
The patient recovered from week to week. She became more alert and mobile. The most beautiful thing was that she laughed again and took part in life. Fortunately, Dr. Probst's acupuncture helped against the nausea that had persisted in the hospital since chemotherapy, because all other known medical and alternative antiemetics had shown no effect on the patient.
The values from the laboratory confirmed the progress: the tumor marker and the bilirubin decreased steadily in large steps while the hemoglobin value increased.
The feeling that Dr. Probst's therapy and the D,L-methadone worked independently in the patient's body and degraded the tumor cells and metastases without damaging healthy cells was so relieving. At last a treatment that showed effect and did not burden additionally, in a cancer type and at a stage where every previous doctor had raised no hope for improvement.
Dr. Probst was already concerned during the treatment about the high levels of inflammation that had appeared in the blood since the therapy in the hospital and could not be reduced even there. A further experiment with an antibiotic was finally unable to counteract the suspected bile duct infection. The patient's former fit body didn't make it anymore.
While she received therapy from Dr. Probst and we took care of her at home, we all felt at every moment that we were doing the right thing. With Dr. Probst, the patient felt herself to be in the best hands and was able to let go and find rest. We knew that the healthy parts of the body were no longer being harmed and that nothing would happen without her and our consent, and we could see her improved quality of life based on her condition and laboratory results. We are very grateful for that.
The gain in time and quality of life, and the decline in disease thanks to D,L-methadone and treatment by Dr. Probst in a stage at which, according to orthodox medicine, nothing more is possible, were so humane and so near a miracle that they are presented in this book as therapy options for cancer. You will also find a detailed description of the further development of Dr. Probst's treatment methods, as well as examples of and interviews with patients who have been able to live without complaints to this day.
Last year I experienced what one actually "knows" as a saying: that ultimately our life is in greater hands and when it is time to leave the body, it will happen. At the same time, as long as we are here on earth and do not know when this moment will be, we can decide for ourselves how we deal with disease, which form of healing and treatment we choose, and whom or what we trust in and around us. I am aware that the therapy I present in this book is only one of many ways to deal with cancer and that there are a number of different treatment methods, all of which have the goal of helping the sick—orthodox, alternative, complementary, spiritual … possibly in combination with each other.
Shortly after I started working on this book, Dr. Probst applied another combination of his therapy components to his patients, with even more amazing results. Based on our experiences and on interviews with him and his patients, I see the biological cancer therapy of Dr. Probst as a very ethical form of physical treatment, as he does not harm the healthy cells of the body and effectively supports human beings in their healing.
Birgit Lekin
Dr. Reinhard Probst ondiagnosis and possibilities
The challenging diagnosis "cancer"
Dr. Probst: The diagnosis cancer challenges, like no other disease, patients, relatives and doctors. No other disease is filled with so many, sometimes even irrational, fears and ideas.”
The diagnosis of a tumor disease is often a catastrophe for the patient, regardless of the prognosis. Doctors who, due to structural deficits, have only a few minutes to deliver the threatening diagnosis, urge patients to decide in the shortest possible time on an operation, usually with prior or subsequent chemotherapy and/or radiation. The machinery gets going, and to the patient it feels like a continuing nightmare. The alternating wash of emotions is enriched with well-intentioned advice, positive or negative experiences from the circle of acquaintances, exaggerated or missing attention.
Does the patient seek care from a naturopathic doctor or alternative practitioner, in which further uncertainty occurs. Either the naturopath turns up his nose at conventional medical therapies, or the oncologists often advise against biological methods without qualification in this area. So, clarification and factual consideration are necessary.
The current situation in oncology
Dr. Probst: While oncologists in the media are full of reports about ever better treatment options for cancer, the epidemiological examination of the facts is much more sobering. Over a period of 40 years, there was no decisive change in survival rates for all tumor types except leukemia. On the contrary, the survival curves of recent years are the worst, although tumors are detected earlier and earlier by improved diagnostic options, and therefore patients should (apparently) live longer.
Disproportionate to the lack of success are the rapidly rising therapy costs for oncological treatments, which, according to a commercial health insurance company, have risen by 240% in the last five years. As convincing as the conventional medical therapy results are for certain forms of leukemia, testicular tumors and ovarian carcinomas, they are less effective for other solid carcinomas, which make up the majority of cancer diagnoses. In 2004, an Australian expert group analyzed all US and Australian oncological studies published between 1990 and 2004 and came to the conclusion that chemotherapy contributed only slightly more than 2% to the improvement in the five-year survival rate of cancer patients! And even this figure is doubtful, as it is based only on studies carried out by the pharmaceutical industry itself. The pressure exerted on patients to undergo chemotherapeutic treatment with its strong side effects